Treatment of autism spectrum disorder and symptoms associated with autism spectrum disorder by probiotic supplementation in subjects with a diagnosis of autism spectrum disorder
CA3329828A1Undetermined Publication Date: 2025-11-06KERRY GRP SERVICES INT LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CA3329828
- Authority / Receiving Office
- CA · CA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-02
- Filing Date
- 2025-05-02
- Publication Date
- 2025-11-06
Abstract
The present invention refers to the use of a composition comprising live Lactobacillus acidophilus , live Lacticaseibacillus paracasei and live Lacticaseibacillus rhamnosus in the treatment of Autism spectrum disorder (ASD) and in the treatment of multiple symptoms associated with ASD, selected from impaired communication, impaired sociability, impaired sensory awareness, impaired cognitive awareness and behaviors, gastrointestinal disorders or sleep disorders. The composition of the present invention is a nutritionally acceptable composition comprising the combination of live Lactobacillus Acidophilus , live Lacticaseibacillus paracasei and live Lacticaseibacillus rhamnosus selected from a group comprising a drinkable solution, a capsule, a tablet, a lozenge, gummies, powders, sachets, stick packs, fermented beverages, juices or yogurt.
Need to check novelty before this filing date? Find Prior Art
